Clinical trials of Covid-19 treatments are taking place in Lithuania and the number of participants could soon be increased to 200, the country's Health Ministry says.
Solidarity is an international clinical trial to help find an effective treatment for Covid-19, launched by the World Health Organization and partners. In Lithuania, the trial is being carried out by Vilnius University's Santara Clinic in Vilnius and the Kaunas Clinic of the Lithuanian University of Health Sciences.
As people with Covid-19 are willingly taking part in the trial, the number of participants is nearing the planned maximum, according to the ministry. Therefore, Santara Clinic has submitted a request to increase the number of trial participants to 200.
The trial is looking into the efficacy and safety of remdesivir, acalabrutinib and interferon beta-1a, compared to the standard Covid-19 treatment. The trial was launched in Lithuania in May and is scheduled to last until April 2021.
The initial planned number of participants was 20 but it has so far been increased to 100.
The Solidarity Trial compares options against standard of care, to assess their relative effectiveness against Covid-19. By enrolling patients in multiple countries, the Solidarity Trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival. Other drugs can be added based on emerging evidence.